Back to results
US 9,801,874 B2Granted
Method for the preparation of liposome encapsulated vincristine for therapeutic use
AssigneesSpectrum Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corporation
InventorsWilliam T. Monte, Christopher James Barbosa, Thomas Philip Weber
Life of this patent
Estimating the term…
Abstract
Improved methods for efficiently constituting liposome encapsulated vincristine for intravenous injection (VSLI) with reduced risk of operational errors and contamination are disclosed.
Claims15
A method of preparing a pharmaceutically acceptable liquid composition comprising liposome-encapsulated vincristine which is free of substantial degradation products, the method comprising:
- (a) constituting in a single vial (i) a first solution comprising vincristine sulfate at a concentration of about 1 mg/ml to about 5 mg/ml, wherein the first solution has a pH of about 3.5 to about 5.5;
- and (ii) a second solution comprising sphingomyelin/cholesterol liposomes at a low pH;
- (b) raising the pH of the constituting solution in the single vial to a pH of about 7.0 to 7.5;
- (c) heating the single vial comprising the constituting solution in a dry heat block equilibrated at about 75° C. for at least about 13 to about 18 minutes, wherein said heat block comprises one or more bores about 1-5% larger than the average length or diameter of the single vial to produce a solution comprising constituted liposome encapsulated vincristine;
- and
- (d) equilibrating the constituted solution to room temperature.
3 more elements
Dependencies are inferred from the claim text.